Program Information

March 5, 2006

Applied Clinical Trials

Applied Clinical Trials, Applied Clinical Trials-03-05-2006, Volume 0, Issue 0

Session Highlights for March 6 and 7

March 6, 2006

09:00-12:30 - Graduates Session


With Speakers from the DIA and National Health Authorities to discuss:

  • Global DIA Activities


  • Drug Development and Registration Process
  • Job Opportunities in Industry & Health Authorities

  • 13:30-14:30DIA Welcome and Awards CeremonyDIA Distinguished Career and
    Outstanding Services Awards Ceremony

  • 14:30-15:30 - Plenary Session Part 1
    EU INNOVATION AND COMPETITIVENESSIntroduction by the Programme Co-Chairpersons

    Iman Barilero, Johnson & Johnson PRD, UK
    Marie Dray, International Regulatory Affairs Group, USA

Key Note Speakers:Georgette Lalis,European Commission,
DG Enterprise and Industry, Belgium
Jean-Franois Dehecq,sanofi-aventis, France

  • 16:00-17:30
    Plenary Session Part 2
    EU INNOVATION AND COMPETITIVENESS:
    PRACTICAL IMPLICATIONS FOR AND
    INVOLVEMENT OF THE STAKEHOLDERSModerators:

    Iman Barilero, Johnson & Johnson PRD, UK and
    Philip Brown, SCRIP, UKPanelists:
    Thomas Lonngren, EMEA, EU
    Martin Terberger, European Commission, Belgium
    Jean Marimbert, AFSSAPS, France
    Yann Le Cam, EURORDIS, France

18:00-21:00
Buffet Reception

March 7, 2006

  • Late breaking news:
    Addition to EuroMeeting Programme,
    Tuesday, March 7

13:00-13:45
Special Session:
An Assessment of the Community System of Pharmacovigilance
Session Moderator: Marie A. Dray
Speaker: Peter Arlett, MD, European Commission, Europe
The European Commission-sponsored study An Assessment of the Community System of Pharmacovigilance was made public in February 2006 and the Commission has launched a public consultation on its results including an invitation to comment on the strengths and weaknesses of the Community System. As part of this consultation, Dr. Arlett will present the study report and attendees will be invited to make comments and pose questions on the Community System of Pharmacovigilance.

  • 09:00-18:30
    Poster Session/Student Poster Session

    Posters selected by the review committee, addressing similar topics to those in the programme, will be on display in the exhibition area. Presenters will make themselves available to discuss their work during the coffee and lunch breaks on Tuesday at Le Palais des Congres.The poster review committee will select the three best student posters, and the winning authors will receive a EuroMeeting Student Poster Prize. The Prizes will be awarded at the student poster award ceremony on Tuesday, March 7, at 17:30 by the DIA booth in the exhibition area.

  • 18:30-20:00
    French Agency Satellite Meeting
    THE INVOLVEMENT OF FRANCE IN THE EUROPEAN NETWORKS FOR EVALUATION AND MONITORING OF HEALTH PRODUCTSGeneral Presentation of AFSSAPS:Missions and Goals - Risk Assessment and Management

    Jean Marimbert, AFSSAPS, FranceRound Table Discussion on the Common Vision on Clinical Trials in France with Representatives of LEEM, INSERM and AFSSAPS**If you are registered for the EuroMeeting, then you will have access to enter in the satellite meeting without registering separately.

Related Content:

News